
The new deal will add roughly 2,000 titles (approximately at 15% increase) to Amazon’s Instant Video service and make them a larger competitor in the on-demand streaming content service industry. The deal doesn’t give Amazon exclusive rights to the content, as many of the titles are already available on other services such as Netflix (NASDAQ:NFLX) and Hulu.
Amazon is betting that the increase in their library will, in part, help bolster sales of their Kindle Fire line of computer tablets. Subscribers to Amazon’s Prime service will now be able to watch popular shows such as MTV’s “Jersey Shore,” TV Land’s “Hot in Cleveland,” and kids shows like “Dora the Explorer,” amongst others, on Wednesday. Amazon currently sells their Kindle Fire at a loss, but makes up for it on sales for products and content for the Fire.
Amazon has also recently inked deals with others, including News Corp.’s Fox and Warner Bros. to add more films and shows to its offerings and compete in the crowded industry. “You either have to build the device that everyone wants or have a price point that excites people and an ecosystem that goes around that,” commented Kerry Rice, an analyst with Needham & Co. in San Francisco, who recommends holding Amazon shares. It seems apparent that “the device that everyone wants” comment by Rice is a reference to the Apple iPad, which is significantly higher priced than all competitors, but selling off the shelves for Apple, Inc. (NASDAQ:AAPL) as the top selling tablet on the market.
In a broader scope, the deal puts additional pressure on Netflix, especially with the recent deal struck between Verizon (NYSE:VZ) and Coinstar (NASDAQ:CSTR), parent company of video kiosk giant Redbox, to launch initiatives of their own to expand their presence in the on demand space.
Amazon (AMZN) Stock Quote and News:
Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.









According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the
0 comments
Add your comment
Commenting is allowed only for registered users.